Pharmacokinetics of phillyrin and forsythiaside following iv administration to Beagle dog

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 34, Issue 2, 2009, Pages 79-83

  Li, Yun Xia ^a   Peng, Cheng ^a   Zhang, Ruo Qi ^b   Li, Xue ^b   Jiang, Xue Hua ^b  

^a CHENGDU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Beagle dog; Forsythiaside; Pharmacokinetics; Phillyrin

Indexed keywords

FORSYTHIASIDE; GLYCOSIDE; LIGNAN DERIVATIVE; PHILLYRIN; UNCLASSIFIED DRUG; GLUCOSIDE; HERBACEOUS AGENT;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MEGADOSE; EXPERIMENTAL DOG; LOW DRUG DOSE; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; NONHUMAN; ANIMAL; DOG; DOSE RESPONSE; HALF LIFE TIME; INTRAVENOUS DRUG ADMINISTRATION; TISSUE DISTRIBUTION;

ANIMALS; AREA UNDER CURVE; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; GLUCOSIDES; GLYCOSIDES; HALF-LIFE; INJECTIONS, INTRAVENOUS; TISSUE DISTRIBUTION;

EID: 68949088658     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03191155     Document Type: Article

References (27)

1. YoshidaT., Sakane N., Wakabayashi Y., et al. (1995): Thermogenic anti-obesity effects of bofu-tsusho-san in MSG-obese mice. Int. J. Obes. Relat. Metab. Disord., 19, 717-722.
2. Sato Y., Kumazawa N., Suzuki M., et al. (1991): Studies on chemical protectors against radiation. XXXIII. Protective mechanisms of various compounds against skin injury induced by radiation. Yakugaku Zasshi, 111, 51-58.
3. Schinella CR., Tournier H.A., Prieto J.M., et al. (2002): Synthesis and opioid activity of new fentanyl analogs. Life Sei., 9, 1023-1033.
4. Bing Qing, Wei Qi, Xing Hong, et al. (1999): study on the anti-inflammatory and analgesia function of fructus forsythia extraction. Zhong Cao Yao, 30, 43-45.
5. Yang Tiang-ming, Zhang Zhi-hai, Zhang-hong, et al. (2003): study on the anti-bacteria function of Water extraction fructus forsythia. J. Lanzhou Med. Coll., 9, 40-42.
6. Liu Ying-juan, Yang Zhan-qiu, Xiao Hong, et al. (2004) effective component in vitro anti-fever blisters virus's experimental study on the Chinese medicine fructus forsythia. J. Hubei Coll. TCM, 6, 36-37
7. Liu J., Zhang L.W., (2006): Functions of Forsythiaside on the Damage of DNA Induced by Hydroxyl Radical. J. Shanxi Med. Univ., 7. 23-24.
8. Ishizuka O., Kumazawa N., Ohta S., et al. ( 1992): Effects of various methanol extracts of crude drugs on experimental subacute and chronic hepatic injury. Yakugaku Zasshi, 112, 174-182.
9. Kumazawa N., Ohta S., Ishizuka O., et al. (1990): Protective effects of various methanol extracts of crude drugs on experimental hepatic injury induced by carbon tetrachloride in rats. Yakugaku Zasshi, 110, 950-957.
10. Jin H., Zuo J.F., Li J.S. (2006): Study on the pharmacology of phenylethanoid glycosides. Lishizhen Med. Materia Med. Res., 17, 440-444.
11. Diaz Lanza A.M., Abad Martinez M.J., Fernandez Matellano L. (2001): Lignan and phenylpropanoid glycosides from Phillyrea latifolia and their in vitro anti-inflammatory activity. Planta Med., 67, 219-223.
12. Chen X., Zhang J., Xue C, et al. (2004): Simultaneous determination of some active ingredients in anti-viral preparations of traditional Chinese medicine by micellar electrokinetic chromatography. Biomed. Chromatogr., 18, 673-680.
13. Shi Y., Shi R.B., Liu B., et al. (2003): Isolation and elucidation of chemical constituents with antiviral action from yinqiaosan on influenza virus. Zhongguo Zhong Yao Za Zhi, 28, 43-47. (Pubitemid 41250692)
14. Zhao Yong-mei, Li Fa-rong (2005): Study on the reducing blood lipid and antioxidition effects of phillyrin. Nat. Prod. Res. Dev., 17, 157-159.
15. Zhao Y., Li F., Yang J., et al. (2005): Effect of phillyrin on the anti-obesity in nutritive obesity mice. Zhong Yao Cai, 28, 123-124.
16. Tamotsu Nikaido, Taichi Ohamoto and Takeshi Kinoshita. (1981): Inhibition of Cyclic AMP Phosphodiesterase by Lignans. Chem. Pharm. Bull., 29, 3586-3606.
17. Kuang H.X., Zhang N and Lu Z.B. (1988) Antibacterial constituents of the unripe fruit of Forsythia suspensa (Thunb.) Vahl. Zhong Yao Tong Bao, 13, 32-34, 62-63.
18. Hu J.K., Xu K.J., Wang Y.H. et al. (2001): Study on the in vitro antiviral effect of forsythiaside. J. Chin. Tra. Med. Sci. Tech., 8, 89-91.
19. Zhang L.W., Zhao CC, Yang P. (2003): Study on the antioxidant activity and structure-activity relationship of forsythiaside. Chin. Pharmac. J., 38, 334-336.
20. Hu J.K., Qu F.J., Sun K.X et al. (2004): Experiment study on the induction of α-interferon of human leucocyte in vitro by forsythiaside. J. Chin. Tra. Med. Sci. Tech., 11, 355-356.
21. Li Yunxia, Jiang Xuehua, Huang Liang et al. (2006): Determination of phillyrin in rat plasma by highperformance liquid chromatography and its application to pharmacokinetic studies, J. Pharm. Biomed. Anal., 41, 628-632.
22. Li Y.X., Jiang X.H., Liang H.Y., et al. (2008) Determination of forsythiaside in rat plasma by high-performance liquid chromatography and its application to pharmacokinetic studies. Biomed. Chromatogr., 22, 361-366
23. Chiou, W. L. (1978) Critical evaluation of potential error in pharmacokinetic studies using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve. J. Pharmacokinet. Biopharm., 6, 539-546.
24. Gibaldi M., Perrier D. (1982): Pharmacokinetics. New York.
25. Chiou, W.L. (1980): New calculation method of mean total body clearance of drugs and its application to dosage regimens. J. Pharm. Sci., 69, 90-91.
26. Chiou, W.L. (1979): New calculation method for mean apparent drug volume of distribution and application to rational dosage regimen. J. Pharm. Sci., 68, 1068-1069.
27. Eatman, F.B., Colburn, W.A., Boxenbaum, H.C., et al. (1977): Pharmacokinetics of diazepam following multiple dose oral administration to healthy human subjects. J. Pharmacokinet. Biopharm., 5, 481-494.